2013 FDA Drug Approval Calendar
TheStreet.com
- Adcetris
- Amag Pharmaceuticals
- Amarin
- Antares
- Auxilium
- Aveo Pharmaceuticals
- Cubist Pharmaceuticals
- dabrafenib
- Delcath
- Depomed
- Dolutegravir
- drug approvals
- efinaconazole
- Entereg
- Feraheme
- Gilead
- GSK
- Melblez
- Merck
- Otrexup
- Seattle Genetics
- Sefelsa
- sofosbuvir
- suvorexant
- tivozanib
- Trametenib
- Valeant Pharmaceuticals
- Vascepa
- Xiaflex
- Zogenix
- Zohydro
Cubist says antibiotic regimen will get a fast-track review as a treatment for 3 infections
Yahoo/AP
This Week in Biotech
Motley Fool
Trius Therapeutics: Takeover Candidate In 2013
Seeking Alpha
Cubist Pharma Earnings: A Mixed Reaction to Analyst Estimates
Wall St. Cheat Sheet